What Do Minimal Luminal Irregularities Mean?

Minimal luminal irregularities on a coronary angiogram or CT scan describe slight roughness or unevenness in the inner wall of a coronary artery, typically representing early atherosclerotic plaque that narrows the vessel by less than about 30%. In practical terms, this is the earliest visible footprint of coronary artery disease. Short-term prognosis is generally good, but the finding is far from meaningless, and the story of what happens next depends on risk factors, the type of plaque involved, and how aggressively you and your doctor manage the underlying process.

What Counts as a Minimal Luminal Irregularity

When a cardiologist reads an angiogram or a coronary CT angiography (CCTA) scan, they are looking at the channel through which blood flows, the “lumen.” A perfectly smooth lumen means no detectable plaque. A lumen that shows slight waviness, small notches, or minor bumps without causing meaningful flow restriction is described as having minimal luminal irregularities. In most clinical contexts, this corresponds to a narrowing of roughly 1% to 30% of the vessel diameter.

The widely used CAD-RADS reporting system, updated in 2022 by a consortium of cardiovascular societies, classifies coronary disease on a scale from 0 (no plaque or stenosis at all) to 5 (total occlusion). Minimal irregularities generally fall into CAD-RADS 1, meaning plaque is present but stenosis is less than 25%, or occasionally the low end of CAD-RADS 2 (25–49% stenosis).1PubMed Central. CAD-RADS™ 2.0 – 2022 Coronary Artery Disease – Reporting and Data System An Expert Consensus Document of the Society of Cardiovascular Computed Tomography (SCCT), the American College of Cardiology (ACC), the American College of Radiology (ACR) and the North America Society of Cardiovascular Imaging (NASCI) The classification is based on the single most severe lesion found anywhere in the coronary tree, so even one spot of minimal irregularity changes a report from “normal” to “disease present.”

One thing worth knowing: conventional angiography shows only the lumen, not the artery wall itself. A vessel can harbor considerable plaque that grows outward into the wall rather than inward toward the blood flow, a phenomenon called positive remodeling. What looks like a minor irregularity on an angiogram can, in some cases, conceal more advanced disease than the image suggests. This is one reason newer imaging tools like intravascular ultrasound and optical coherence tomography are sometimes used when the angiographic picture does not match the clinical story.

Why Minor Irregularities Still Carry Risk

The intuition most people have when they hear “minimal” is reassuring, and that instinct is partly correct. But the research consistently shows that any visible coronary plaque, even if it does not restrict blood flow, places you on a risk continuum with people who have more advanced disease. A large retrospective study of over 37,000 U.S. military veterans who underwent elective coronary angiography found a clear gradient of risk for heart attack based on the extent of disease. Using patients with no apparent coronary disease as the baseline, those with nonobstructive disease in just one vessel had roughly double the risk of heart attack within a year. With nonobstructive disease in two vessels, the hazard ratio climbed to about 4.6.2Mayo Clinic Proceedings. Nonobstructive Coronary Artery Disease: More Than Marginal Lesions – Section: Conceptualizing CAD as a Continuum In other words, there is no clean threshold below which plaque is completely harmless. The jump from “no disease” to “a little disease” is the steepest relative increase in risk.

Part of the reason is that heart attacks do not always originate from the tightest blockages. Plaque can rupture at sites where narrowing is modest but where the plaque cap is thin and the fatty core is large and inflamed. Postmortem studies have identified clear structural features of these so-called vulnerable plaques, and both invasive and noninvasive imaging techniques are getting better at spotting them in living patients.3Circulation: Cardiovascular Imaging. Early Detection and Treatment of the Vulnerable Coronary Plaque: Can We Prevent Acute Coronary Syndromes? A minimal irregularity on an angiogram does not tell you whether the underlying plaque is stable or vulnerable, which is one reason why the finding warrants follow-up rather than dismissal.

How Quickly Do Irregularities Progress

Not everyone with minimal irregularities will develop significant coronary disease, but a substantial fraction do over the following years. A study that tracked patients with either angiographically normal coronary arteries or minor irregularities (narrowing of 30% or less) over a 15-year window found that disease progression occurred in about 81% of those who started with minor irregularities, compared with 41% of those whose arteries initially looked completely clean.4PubMed. Late angiographic follow-up in adults with initial angiographic normal or minimally narrowed coronary arteries Patients in the irregularity group lost an average of about 6% of luminal diameter per year, whereas those with initially normal arteries progressed at roughly 2.6% per year.5American Journal of Cardiology. Prognosis of Normal Coronary Arteries – Section: Results

The researchers also noted that even in the “normal coronary arteries” group, about 11% eventually suffered a heart attack, reinforcing the idea that angiography can miss early disease. The short-term prognosis for people with minimal irregularities is quite good, but the long-term picture is less benign, especially when conventional risk factors are in play.

An earlier study looking specifically at predictors of progression in patients with normal or minimally narrowed arteries found that the strongest predictors were the number of arterial segments already showing some disease, age, smoking status, and cholesterol level. Among 31 patients with minimal disease, about half showed progression. Using a statistical model incorporating those four factors, the researchers could separate patients into groups with no progression, moderate risk, and high risk, with all 10 patients classified as high-risk showing progression on follow-up.6PubMed. Factors associated with progression of coronary artery disease in patients with normal or minimally narrowed coronary arteries The practical upshot: a finding of minimal irregularities in a nonsmoking 40-year-old with excellent cholesterol may follow a very different trajectory than the same finding in a 60-year-old smoker with high LDL.

Symptoms Despite Minimal Blockage

One of the more frustrating experiences for patients is having real chest pain or exercise-related discomfort yet being told their arteries look “basically normal.” Minimal luminal irregularities on an angiogram do not explain symptoms through flow restriction in the large arteries, because a 20% or 30% narrowing does not meaningfully limit blood delivery. But the problem may lie downstream, in the microvascular circulation, the tiny arteries and arterioles that an angiogram cannot visualize.

A study comparing patients with nonobstructive stenosis to those with no visible stenosis at all found that coronary microvascular dysfunction was actually more common in patients whose arteries appeared completely clean than in those with some visible plaque.7PubMed Central. Effect of nonobstructive coronary stenosis on coronary microvascular dysfunction and long-term outcomes in patients with INOCA This may sound counterintuitive, but the explanation is that when angiography shows some degree of plaque, that plaque may at least partially account for the patient’s symptoms. When there is truly no visible disease and the patient still has problems, the dysfunction is more likely to be microvascular, happening at a scale the angiogram cannot resolve.

For patients who have angina and near-normal angiograms, the treatment picture is muddled compared with classic coronary artery disease. No large randomized trials have directly compared therapies for reducing cardiac events in this group. Observational evidence suggests that beta-blockers are the most effective medication for reducing chest pain episodes during daily life. Calcium channel blockers, despite being widely prescribed, appear to do less to prevent chest pain and do not improve diminished coronary blood flow reserve. Nitrates help some patients anecdotally but have not been studied in controlled settings for this population, and a placebo effect cannot be ruled out.8JAMA. Angina With “Normal” Coronary Arteries: A Changing Philosophy – Section: Therapeutic Strategies The tricyclic antidepressant imipramine has shown benefit in patients with abnormal cardiac pain perception, possibly through a visceral analgesic effect rather than a cardiac one.

When the Irregularity Is Not Atherosclerotic Plaque

Not every luminal irregularity on imaging is plaque. A few conditions can mimic it, and distinguishing among them matters because the treatment and implications are different.

  • Catheter-induced spasm: During cardiac catheterization, the catheter itself can trigger temporary arterial spasm that looks like a fixed narrowing on the angiogram. A review of 33 patients with angiographic coronary artery spasm and no significant underlying blockage found that about half of them had spasm provoked by the catheter rather than spontaneous vasospastic angina.9PubMed. Catheter-induced coronary artery spasm: an angiographic manifestation of vasospastic angina? If an irregularity appears during the procedure but was not present on a prior CT scan, spasm is a possibility.
  • Fibromuscular dysplasia: This is a non-atherosclerotic, non-inflammatory condition of the arterial wall that causes segments of narrowing, aneurysm, dissection, or twisting in medium-sized arteries.10DeckerMed Vascular and Endovascular Surgery. Fibromuscular Dysplasia – Section: Abstract On imaging, it can produce a “string of beads” appearance or isolated irregularities that look like plaque but behave differently and carry different risks.
  • Myocardial bridging: In some people, a segment of a coronary artery dips beneath the heart muscle rather than riding on its surface. During each heartbeat, the muscle squeezes the buried segment, causing temporary compression that can appear as an irregularity or dynamic narrowing on angiography. One study comparing CT and invasive angiography in 300 patients found dynamic compression in about 13% of cases.11PubMed. Frequency of myocardial bridges and dynamic compression of epicardial coronary arteries: a comparison between computed tomography and invasive coronary angiography Myocardial bridges are usually benign but can occasionally cause symptoms, especially during exercise.

If your report mentions minimal luminal irregularities and you have no traditional risk factors for atherosclerosis, asking your cardiologist whether any of these non-plaque explanations were considered is reasonable.

Managing the Finding

When minimal luminal irregularities do represent early atherosclerosis, the management strategy focuses on slowing or reversing plaque progression. Statins are the cornerstone, and there is evidence that they can actually shrink coronary plaque, though the effect depends on starting cholesterol levels. A study using intravascular ultrasound to measure plaque volume found that statin therapy led to plaque regression in patients with moderate and high baseline cholesterol levels, with reductions averaging around 3% of plaque volume. In patients who already had low non-HDL cholesterol (roughly 140 mg/dL or below), plaque actually continued to grow despite statin treatment, suggesting that the benefit is greatest when there is substantial cholesterol to lower.12PubMed Central. Efficacy of Statin Therapy in Inducing Coronary Plaque Regression in Patients with Low Baseline Cholesterol Levels

Statins and ACE inhibitors also improve endothelial function, the ability of the artery lining to relax and regulate blood flow, which may be impaired even before significant blockage develops.13JAMA. Angina With “Normal” Coronary Arteries: A Changing Philosophy For patients with early disease and endothelial dysfunction, these medications may address the underlying process rather than just the cholesterol numbers.

Lifestyle interventions add a distinct layer of benefit. A randomized study examined patients with nonobstructive coronary disease who were already on optimal medical therapy and found that adding a controlled diet and lifestyle program slowed plaque progression and reduced the volume of noncalcified plaque compared with medication alone.14PubMed. High-Risk Coronary Plaque Regression After Intensive Lifestyle Intervention in Nonobstructive Coronary Disease: A Randomized Study Noncalcified plaque is the type most associated with rupture risk, so shrinking it specifically is a meaningful outcome. Exercise training has also been shown to reduce chest pain recurrences in patients with near-normal angiograms, potentially by modulating the adrenergic (stress-hormone) drive that promotes ischemia.13JAMA. Angina With “Normal” Coronary Arteries: A Changing Philosophy

The message is not that minimal irregularities require aggressive intervention in every patient. Rather, they represent an actionable window. The same risk factors that predict progression, namely smoking, high cholesterol, and age, are partly modifiable. Addressing them early, when the disease burden is low, is likely to pay larger dividends than waiting until blockages become significant.

Luminal Irregularities Outside the Heart

The term “luminal irregularities” is not exclusive to coronary arteries. It comes up in the carotid arteries, the major blood supply to the brain, and the implications there have become increasingly recognized. Nonstenotic carotid plaque, meaning plaque that does not narrow the vessel by more than 50%, is now considered a likely cause of a meaningful fraction of strokes that were previously classified as “cryptogenic,” or unexplained.

Research on patients with embolic strokes of undetermined source found that nonstenotic plaque in the carotid artery feeding the affected brain territory was more common than would be expected by chance, and was specifically more prevalent in the parent artery than in arteries supplying unaffected brain regions. Estimates suggest that more than 20–30% of patients with one-sided embolic strokes of unknown cause may have their events attributable to nonstenotic carotid plaque.15PubMed Central. The Attributable Risk of Nonstenotic Cervical Carotid Plaque in Cryptogenic Embolic Stroke This is a substantial shift in thinking, because clinical guidelines have traditionally focused on carotid stenosis above 50–70% as the threshold for intervention. Recognizing that minor plaque can be dangerous in the carotid bed is changing how stroke specialists approach patients whose imaging shows irregularities but no hemodynamically significant narrowing.

How AI Is Changing Plaque Assessment

One of the limitations of reading coronary CT scans or angiograms by eye is that you are largely stuck with estimating the degree of narrowing. Newer artificial intelligence tools can quantify plaque composition and volume from a standard CT scan, picking up details that a human reader may classify simply as “minimal irregularity.” These AI-driven analyses measure things like total plaque volume, the ratio of calcified to noncalcified plaque, and the percentage of the artery wall occupied by plaque.

A study from the CONFIRM2 registry analyzing over 3,500 patients with AI-quantified CT found that men had significantly more total plaque, more high-risk plaque features, and higher rates of major adverse cardiovascular events (about 6% over roughly five years, compared with about 3% in women). However, when the same plaque features were present in women, they carried a higher relative risk of adverse events than in men, even after adjusting for age and other cardiovascular risk factors.16Circulation: Cardiovascular Imaging. AI-Quantitative CT Coronary Plaque Features Associate With a Higher Relative Risk in Women: CONFIRM2 Registry The implication is that a woman whose CT shows what looks like minimal irregularity but whose AI-quantified plaque volume or composition crosses certain thresholds may face higher risk than a man with a similar-looking scan. As these tools become more available, the binary “minimal irregularity versus significant stenosis” distinction will likely be replaced by a more granular risk profile based on what the plaque is made of and how much of it there is.

The Psychology of a “Minor” Finding

There is an underappreciated human dimension to receiving a report that says minimal luminal irregularities. Some patients hear “minimal” and assume it means “nothing to worry about,” leading them to deprioritize risk factor management. Others fixate on the word “disease” and experience disproportionate anxiety. Neither reaction is ideal.

Research on how patients perceive cardiovascular risk suggests that people who believe their personal risk of a heart attack is higher are more likely to adhere to statin therapy and other preventive measures. In one study, patients who self-rated their 10-year heart attack risk as high were roughly half as likely to be non-adherent to statins compared with those who rated their risk as very low.17PubMed Central. Patient-reported adherence to statin therapy, barriers to adherence, and perceptions of cardiovascular risk The problem is that clinical risk categories alone did not predict adherence; what mattered was the patient’s own perception of their risk. A finding of minimal luminal irregularities, if communicated clearly, could serve as a concrete anchor that helps a patient take early atherosclerosis seriously without catastrophizing. The challenge for clinicians is framing it as a reason to act, not a reason to panic or, equally, to shrug.

If you have received this finding on a report, the most productive interpretation is probably this: you have visible evidence that the atherosclerotic process has started, your short-term risk is low, and you are in a position where modifying risk factors can genuinely change the trajectory of your disease. Whether that means starting or intensifying statin therapy, quitting smoking, adopting a structured exercise program, or some combination depends on the rest of your clinical picture. But treating minimal irregularities as a call to action rather than a verdict is the reading that best matches what the evidence shows about where early plaque can go and what you can do about it.